Перевести на Переведено сервисом «Яндекс.Перевод»

Infinity Pharmaceuticals

Country
USA
Краткое название
Infinity Pharmaceuticals
Headquarters
780 Memorial Drive
Members of the board

Julian Adams, Ph.D. — President, Research and Development
Lawrence E. Bloch, MD, JD — Executive Vice President, Chief Financial Officer and Chief Business Officer
Joshua D. Hamermesh — Vice President, Business and Corporate Development
John J. Keilty — Vice President, Information Technology and Informatics
Jeanette W. Kohlbrenner — Vice President, Human Resources
Christopher M. Lindblom — Vice President, Accounting and Financial Planning
Vito J. Palombella, Ph.D. — Chief Scientific Officer
Adelene Q. Perkins — President and Chief Executive Officer
Pedro Santabarbara M.D., Ph.D. — Chief Medical Officer
Tamyra A. Toole, Esq. — Vice President, Regulatory Affairs and Quality Assurance
Winselow S. Tucker Jr. — Vice President, Marketing

Categories medicine
Oncology, Rheumatology
Stage of the project
Production
Disease
Rheumatoid arthritis, Bronchial asthma, Lung cancer
Ticker
INFI
Current owners

Martin Babler
Anthony B. Evnin, Ph.D.
Gwen A. Fyfe, M.D.
Eric S. Lander, Ph.D.
Patrick P. Lee
Thomas J. Lynch, M.D.
Adelene Q. Perkins
Norman C. Selby
Ian F. Smith
Michael C. Venuti, Ph.D.

Assets
535.0500
Technology
Cell Technologies, Devices, Technologies, Pharmaceuticals, Chemistry